Financials data is unavailable for this security.
View more
Year on year Anhui Huaheng Biotechnology Co Ltd grew revenues 36.63% from 1.42bn to 1.94bn while net income improved 40.32% from 320.03m to 449.06m.
Gross margin | 30.29% |
---|---|
Net profit margin | 13.97% |
Operating margin | 15.36% |
Return on assets | 7.86% |
---|---|
Return on equity | 16.80% |
Return on investment | 12.64% |
More ▼
Cash flow in CNYView more
In 2023, Anhui Huaheng Biotechnology Co Ltd increased its cash reserves by 139.83%, or 205.52m. Cash Flow from Financing totalled 1.02bn or 52.86% of revenues. In addition the company generated 301.42m in cash from operations while cash used for investing totalled 1.13bn.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 8.13 |
---|---|
Tangible book value per share | 7.69 |
More ▼
Balance sheet in CNYView more
Current ratio | 0.6043 |
---|---|
Quick ratio | 0.4316 |
Total debt/total equity | 1.10 |
---|---|
Total debt/total capital | 0.5241 |
More ▼
Growth rates in CNY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 45.00% and 38.97%, respectively. The positive trend in dividend payments is noteworthy since only some companies in the Food Processing industry pay a dividend. Additionally, five year annualized earnings per share growth ranks above the industry average relative to its peers.
Div yield(5 year avg) | -- |
---|---|
Div growth rate (5 year) | -- |
Payout ratio (TTM) | 47.27% |
EPS growth(5 years) | 20.38 |
---|---|
EPS (TTM) vs TTM 1 year ago | -30.02 |
More ▼